Khaled Ibrahim Abu Haliqa
Consultant oncology, neurosurgery and ophthalmology.
|
Name in Arabic:
خالد ابراهيم أبو حليقة
|
|
|---|---|
|
Nationality:
Emirati
|
|
|
Country of Residence:
United Arab Emirates
|
|
Khaled Ibrahim Abu Haliqa's Bio
Consultant oncology, neurosurgery and ophthalmology.
He is the first Emirati doctor specializing in eye oncology in the world, and a consultant in reconstructive eye surgery at the Eye Institute at Cleveland Clinic Abu Dhabi since September 2020, and Vice President of the Emirates Ophthalmology Society since December 2018, and Secretary General of the Emirates Ophthalmology Society. Medical Center since 2018, and a member of the Irish Medical Association since 1999.
He served as a consultant and head of the ophthalmology department at Sheikh Shakhbout Medical City between 2019 and 2020, as an ophthalmology consultant at Mediclinic Airport Road Hospital in the Emirates between 2018 and 2020, and as an ophthalmology consultant at Abu Dhabi Health Services Company “ SEHA ” between 2011 and 2020.
He also held several positions at Mafraq Hospital , namely: Consultant in Ophthalmology between 2011 and 2020, Head of the Academic Affairs Department between 2016 and 2019, and Director of the Residency Program between 2011 and 2018.
He worked at “Princess Margaret Hospital” in Canada, known today as “Princess Margaret Cancer Centre,” and was a resident physician in the Department of Ophthalmology at both the “University of Toronto” in Canada between 2003 and 2008, and “Mafraq Hospital” between 1999 and 2011.
He has more than 22 years of experience in nasolacrimal duct obstruction, eyelid cancer, ophthalmopathy associated with thyroid disease, and neuro-ophthalmology cases, and has a number of scientific studies published in the field of ophthalmology and surgery.
He won the “Best Young Surgeon Award” in 2014 at the Arab Health Exhibition and Conference.
He received a fellowship in ophthalmic plastic and reconstructive surgery in 2011 from McMaster University in Canada, a fellowship in ocular and orbital tumors from the same university, a fellowship in strabismus and ocular neurology in 2009 from the University of Toronto in Canada, and a fellowship from the Royal College of Physicians and Surgeons. In Canada in 2008 from the same university.
He holds a PhD in Ocular Oncology from McMaster University, and a Bachelor of Medicine and Surgery in 1998 from the Royal College of Surgeons in Ireland (RCSI).




